Latest filing published 20 Oct 2026 for Rallybio Corp, €7,559.
Filing timeline
BuySaleInsider track record
Paula Soteropoulos: trading record in brief
Filings by Paula Soteropoulos span 4 companies, the busiest being uniQure N.V., Akcea Therapeutics, Inc. and Dianthus Therapeutics, Inc. /DE/. In total, 39 filings cover trades dated from 26 January 2018 to 16 October 2026.
On the market, this insider has only sold: 17 sales, €2.7M in total. The rest of the record consists of 9 share grants and 13 option exercises. Since January 2026: no purchases and 1 sale on the market.
The record was last updated on 20 October 2026 with an option exercise (€7,559) in Rallybio Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Paula Soteropoulos
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,562 shares@ US$2.38Common StockSEC:0001193125-26-426875:0
- 599 shares@ US$8.441.8% of flowCommon StockSEC:0001692444-26-000006:0
- 599 shares@ US$80.1116.8% of flowCommon StockSEC:0001692444-26-000006:1
- 27,594 shares@ US$8.4481.4% of flowCommon StockSEC:0001692444-26-000003:0
- 2,220 shares@ US$5.1414.8% of flowOrdinary SharesSEC:0000904454-24-000369:0
- 8,700 shares0Ordinary SharesSEC:0000904454-23-000402:0
- 384 shares@ US$19.9710.1% of flowOrdinary SharesSEC:0000899243-23-006589:0
- 6,000 shares@ US$5.3741.5% of flowOrdinary SharesSEC:0000904454-23-000031:0
- 3,000 shares@ US$5.3721.2% of flowOrdinary SharesSEC:0000904454-22-000633:0
- 6,200 sharesOrdinary SharesSEC:0000904454-22-000601:0
- 9,080 shares0Ordinary SharesSEC:0000904454-22-000356:0
- 596 shares@ US$16.8712.5% of flowOrdinary SharesSEC:0000904454-22-000211:0
- 1,534 shares0Ordinary SharesSEC:0000904454-22-000189:0
- 2,063 shares0Ordinary SharesSEC:0000904454-20-000259:0
- 1,300 shares@ US$60.585.7% of flowOrdinary SharesSEC:0000904454-20-000154:0
- 822 shares@ US$61.533.7% of flowOrdinary SharesSEC:0000904454-20-000154:1
- 807 shares@ US$62.193.6% of flowOrdinary SharesSEC:0000904454-20-000116:0
- 3,000 shares@ US$72.1815.2% of flowOrdinary SharesSEC:0000904454-20-000011:0
- 2,000 shares@ US$5.370.8% of flowOrdinary SharesSEC:0000904454-19-000749:0
- 2,000 shares@ US$70.509.9% of flowOrdinary SharesSEC:0000904454-19-000749:1
- 1,700 shares@ US$63.697.6% of flowOrdinary SharesSEC:0000904454-19-000737:0
- 7,382 shares@ US$64.3933.6% of flowOrdinary SharesSEC:0000904454-19-000737:1
- 2,500 shares@ US$67.5012.0% of flowOrdinary SharesSEC:0000904454-19-000737:2
- 1,711,079 shares@ US$6.4828.1% of flowCommon StockSEC:0001209191-19-051139:0
- 1,113,492 shares@ US$16.6447.0% of flowCommon StockSEC:0001209191-19-051139:1
25 of 39 declarations
